Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-16-006926
Filing Date
2016-08-19
Accepted
2016-08-19 16:38:47
Documents
1
Period of Report
2016-08-17

Document Format Files

Seq Description Document Type Size
1 form4-08192016_010837.html 4  
1 form4-08192016_010837.xml 4 7732
  Complete submission text file 0001415889-16-006926.txt   9244
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MABVAX THERAPEUTICS HOLDINGS, INC. 11588 SORRENTO VALLEY ROAD, SUITE 20 SAN DIEGO CA 92121
Business Address
HANSEN JOHN DAVID (Reporting) CIK: 0001186123 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37861 | Film No.: 161843552